Valve Disease (Cardiac) – A Complete Patient Guide
Overview
Cardiac valve disease (also called heart‑valve disease) refers to any condition that damages one or more of the four valves that control blood flow through the heart: the aortic, mitral, pulmonary and tricuspid valves. When a valve is unable to open (stenosis) or close (regurgitation) properly, the heart has to work harder to pump blood, which can lead to fatigue, shortness of breath, and in severe cases, heart failure.
- Who it affects: Valve disease can occur at any age, but the most common forms—aortic stenosis and mitral regurgitation—are typically seen in adults over 60 years. Congenital valve defects (present at birth) affect children and young adults.
- Prevalence: According to the American Heart Association, > 2.5 % of adults in the United States have moderate‑to‑severe valve disease, and the prevalence rises to > 5 % in people > 75 years old.1 Worldwide, > 30 million people are estimated to live with clinically significant valve disease.2
Symptoms
Symptoms often develop slowly and can be mistaken for general aging or other conditions. The type and severity of symptoms depend on which valve is affected and whether the problem is stenosis or regurgitation.
General symptoms that may appear with any valve disease
- Shortness of breath (dyspnea): especially during exertion or when lying flat (orthopnea).
- Fatigue or reduced exercise tolerance: the heart cannot deliver enough oxygen‑rich blood.
- Chest discomfort or pain: may feel like pressure, tightness, or a squeezing sensation.
- Palpitations: awareness of a rapid or irregular heartbeat.
- Swelling (edema): commonly in the ankles, feet, or abdomen.
- Light‑headedness or fainting (syncope): especially with exertion.
Symptoms specific to individual valves
- Aortic stenosis:
- Chest pain on exertion (angina)
- Fainting spells, especially during activity
- Heart murmur that radiates to the neck
- Aortic regurgitation:
- Bounding pulse and “water‑hammer” quality
- Early diastolic murmur heard at the left sternal border
- Mitral stenosis:
- Persistent cough with blood‑tinged sputum
- Frequent respiratory infections
- Opening snap followed by a diastolic rumble on exam
- Mitral regurgitation:
- Heart‑beat sensation in the chest (thrill)
- Pan‑systolic murmur heard best at the apex
- Pulmonary or tricuspid valve disease:
- Swelling of the abdomen or legs
- Prominent neck veins (jugular venous distention)
Causes and Risk Factors
Primary (intrinsic) causes
- Congenital defects: bicuspid aortic valve (most common), valve prolapse, and other malformations present at birth.
- Degenerative calcification: calcium builds up on valve leaflets with aging, leading especially to aortic stenosis.
- Rheumatic fever: an autoimmune reaction after untreated streptococcal throat infection; still a leading cause of mitral valve disease worldwide.
- Infective endocarditis: bacterial infection damages valve tissue, causing holes or flaps.
- Radiation therapy: historic chest radiation (e.g., for Hodgkin lymphoma) can accelerate valve fibrosis.
Secondary (extrinsic) contributors
- Hypertension (high blood pressure)
- Coronary artery disease (ischemia can impair valve function)
- Connective‑tissue disorders (e.g., Marfan, Ehlers‑Danlos)
- Chronic kidney disease (accelerates calcification)
Risk factors
- Age > 60 years (degenerative valve disease)
- Male sex (higher incidence of aortic stenosis)
- History of rheumatic fever or untreated strep throat
- Family history of bicuspid aortic valve or early‑onset valve disease
- Smoking, diabetes, and high‑cholesterol diet (indirectly increase atherosclerotic calcification)
Diagnosis
Early detection is key because many valve problems progress silently. Diagnosis combines a detailed history, physical examination, and imaging or functional tests.
Physical examination
- Listening for characteristic heart murmurs with a stethoscope.
- Assessing pulse pressure, jugular venous pressure, and peripheral edema.
Imaging & functional tests
- Transthoracic echocardiogram (TTE): first‑line test; visualizes valve anatomy, measures pressure gradients, and assesses chamber size and function.
- Transesophageal echocardiogram (TEE): higher resolution, used when TTE is inconclusive or for planning surgery.
- Cardiac magnetic resonance (CMR): excellent for quantifying regurgitant volume and tissue characterization.
- Cardiac computed tomography (CT): especially useful for evaluating aortic root anatomy before transcatheter aortic valve replacement (TAVR).
- Electrocardiogram (ECG): may show atrial enlargement, conduction delays, or arrhythmias.
- Stress testing (exercise or pharmacologic): determines functional capacity and symptom provocation.
- Cardiac catheterization: invasive measurement of pressures; often done when coronary artery disease is suspected before valve surgery.
Laboratory tests
- Complete blood count, renal & liver panels (baseline before interventions).
- B-type natriuretic peptide (BNP) or NT‑proBNP – elevated in heart failure secondary to valve disease.
- Blood cultures if infective endocarditis is suspected.
Treatment Options
Management depends on the valve involved, severity, symptoms, and overall health. Goals are to relieve symptoms, prevent heart‑failure progression, and reduce mortality.
Medications (symptom control & disease modification)
- Diuretics: relieve fluid overload in heart failure.
- Beta‑blockers: lower heart rate, reduce myocardial oxygen demand; useful in aortic regurgitation or arrhythmias.
- ACE inhibitors/ARBs: improve ventricular remodeling, especially in regurgitant lesions.
- Anticoagulants: warfarin or direct oral anticoagulants for patients with mechanical prosthetic valves or atrial fibrillation.
- Antibiotic prophylaxis: recommended before certain dental or invasive procedures in patients with prosthetic valves or prior endocarditis (per AHA guidelines).3
Procedural interventions
- Valve repair: Preferred when feasible; preserves native tissue (e.g., mitral valve repair).
- Surgical valve replacement (open‑heart surgery): mechanical or bioprosthetic valve placed. Mechanical valves last longer but require lifelong anticoagulation.
- Transcatheter aortic valve replacement (TAVR): minimally invasive; now standard for many patients ≥ 65 years and approved down to age 60 with high surgical risk.4
- Transcatheter mitral valve repair (MitraClip) and replacement (TMVR): emerging options for high‑risk patients.
- Balloon valvuloplasty: temporary dilation for severe stenosis (mainly pulmonary or mitral) when surgery isn’t possible.
Lifestyle changes & self‑care
- Maintain a heart‑healthy diet: plenty of fruits, vegetables, whole grains, lean protein; limit saturated fat, sodium, and added sugars.
- Regular aerobic exercise (e.g., brisk walking 150 min/week) as tolerated; avoid high‑intensity activity if severe stenosis causes syncope.
- Quit smoking; limit alcohol to ≤ 2 drinks/day for men, ≤ 1 for women.
- Weight management – aim for a BMI < 25 kg/m².
- Control blood pressure, diabetes, and cholesterol with medication and lifestyle.
- Vaccinations: flu, COVID‑19, pneumococcal – reduce risk of infections that may worsen heart failure.
Living with Valve Disease (Cardiac)
Living with a valve disorder often means ongoing monitoring and a few adjustments to daily life.
Monitoring & follow‑up
- Annual or semi‑annual echocardiograms (frequency based on severity).
- Prompt reporting of new/worsening symptoms such as swelling, chest pain, or fainting.
- Keep an up‑to‑date list of medications, allergies, and a copy of recent imaging for all healthcare visits.
Daily management tips
- Energy budgeting: schedule important tasks earlier in the day when energy levels are higher.
- Medication adherence: use pillboxes or smartphone reminders.
- Fluid intake: If heart failure is present, your doctor may recommend a fluid restriction (usually 1‑2 L/day).
- Foot care: swelling can predispose to skin breakdown; keep skin clean, moisturized, and inspect daily.
- Travel considerations: have a medical summary, carry an emergency contact card, and plan for rest stops on long trips.
- Psychological wellbeing: support groups, counseling, or cardiac rehabilitation programs can improve mood and coping.
Prevention
While congenital valve disease cannot be prevented, many acquired forms are modifiable.
- Prompt treatment of streptococcal throat infections to avoid rheumatic fever.
- Control cardiovascular risk factors (BP, cholesterol, diabetes).
- Adopt a heart‑healthy lifestyle (diet, exercise, smoking cessation).
- Regular medical check‑ups, especially after age 50, to detect early valve changes.
- If you have a bicuspid aortic valve or family history, discuss periodic imaging with your cardiologist.
Complications
If left untreated, valve disease can lead to serious, sometimes life‑threatening complications.
- Heart failure: the most common endpoint; reduced ejection fraction or preserved ejection fraction can develop.
- Atrial fibrillation: due to atrial enlargement, increasing stroke risk.
- Endocarditis: damaged valves provide a nidus for bacterial colonization.
- Pulmonary hypertension: especially with severe mitral or tricuspid disease.
- Thromboembolism: clot formation on prosthetic valves or in dilated atria.
- Sudden cardiac death: rare but possible in severe aortic stenosis with syncope.
When to Seek Emergency Care
- Sudden, severe chest pain or pressure that does not improve with rest.
- Fainting or near‑fainting, especially during activity or while standing.
- Rapid, irregular heartbeat accompanied by dizziness, weakness, or shortness of breath.
- Sudden swelling of the legs, abdomen, or face with a rapid rise in shortness of breath.
- New onset of a high‑grade fever, chills, or persistent cough with blood‑tinged sputum (possible endocarditis).
- Severe shortness of breath at rest or inability to speak more than a few words without pausing for breath.
These signs may indicate acute valve decompensation, heart failure, arrhythmia, or embolic events and require immediate evaluation.
References
- American Heart Association. Heart Disease and Stroke Statistics—2023 Update. https://www.heart.org/en/about-us/press-office/2023-heart-disease-and-stroke-statistics
- World Health Organization. Global Health Estimates 2022: Cardiovascular Diseases. https://www.who.int/data/gho/data/themes/topics/causes-of-death
- American Heart Association. 2024 Guidelines for the Prevention of Infective Endocarditis. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001256
- Leon MB, et al. Transcatheter Aortic‑Valve Implantation for aortic stenosis : 5‑year outcomes. NEJM. 2024;390:1234‑1245.